Irish drug that could cure Parkinson’s Disease sold for $446 million
IrishCentral.com

Dr. Jeremy Skillington, Vice President of Business Development for Inflazome, travelled to Philadelphia to participate in our Life Sciences Forum this January. In one of the largest deals in Irish biotech history, Inflazome, based out of Trinity, has been sold to Roche.

The Dublin-based drug sells opening treatment of Alzheimer’s, Parkinson’s, and cardiovascular disease to the market.

An Irish company that develops treatments for inflammatory diseases, a collaboration between Trinity College Dublin and the University of Queensland, has been sold for an up-front payment of $446m (€380m) from Roche, plus additional payments based on the achievement of certain milestones.

Read More

Thank you to our colleagues from the Donegal Local Enterprise Office for sharing information about a new online programme for female entrepreneurs! It is an pre-accelerator designed and tailored to encourage and support female entrepreneurs with ambition to set up scalable businesses, and the interesting thing for you is it’s open to those connected to the Donegal Diaspora as well as those resident in Donegal.

The webpage with further details on the Programme and a link to the Application Form is available here.   

Forbes names ICON in list of Best Employers in America for Women

ICON recognised as top employer for women in anonymous survey of 75,000 employees

DUBLIN–(BUSINESS WIRE) — ICON plc, (NASDAQ: ICLR) a leading global provider of drug development and commercialisation services to the pharmaceutical, biotechnology and medical device industries today announced that it has been recognised in the 2020 Forbes List of America’s Best Employers for Women for the second consecutive year.

Read More